HLA Typing for Transplant Research Report 2024 - Global Market Size, Share, Trends, Opportunities & Forecasts, 2019-2029F

Dublin, May 10, 2024 (GLOBE NEWSWIRE) -- The "HLA Typing for Transplant Market - Global Industry Size, Share, Trends, Opportunity & Forecast, 2019-2029F" report has been added to * ResearchAndMarkets.com's* offering.

Global HLA Typing for Transplant Market was valued at USD 1.02 billion in 2023 and is anticipated to project robust growth in the forecast period with a CAGR of 6.01% through 2029

The Global HLA Typing for Transplant Market is a dynamic and critical sector within the broader healthcare industry, dedicated to the assessment and analysis of Human Leukocyte Antigen (HLA) profiles for organ and tissue transplantation. HLA typing is a fundamental component of the transplant process, as it determines the compatibility between donors and recipients, significantly influencing the success of transplant procedures. This market encompasses a wide range of products and services designed to identify and match HLA profiles, thereby reducing the risk of rejection and improving transplant outcomes.

One of the key drivers of the Global HLA Typing for Transplant Market is the growing demand for organ and tissue transplants due to the rising prevalence of chronic diseases and the aging population worldwide. As the need for transplants increases, so does the demand for accurate and timely HLA typing to ensure compatibility and minimize the risk of graft-versus-host disease (GVHD) or graft rejection. Additionally, advancements in molecular biology and genomics have led to the development of innovative and more precise HLA typing techniques, further fueling market growth.

The market comprises various segments, including HLA typing products, services, and software solutions. HLA typing products typically involve reagents, kits, and instruments for laboratory testing, while services encompass testing and consultation offered by clinical laboratories. HLA typing software plays a crucial role in data management, analysis, and reporting.

North America emerged as the dominant player in the Global HLA Typing for Transplant Market in 2023, holding the largest market share. North America experiences a significant demand for organ and tissue transplants, driven by a large population and a high prevalence of conditions necessitating transplantation. As a result, there is a consistent need for accurate HLA typing to facilitate successful transplantation procedures. North America is a hub for research and development in the field of medical and biotechnology. The region is home to numerous research institutions, pharmaceutical companies, and healthcare organizations that actively contribute to the advancement of HLA typing technologies, leading to a high level of innovation and adoption.

*Rise of High-Throughput Platforms*

The Global HLA Typing for Transplant Market is experiencing a significant boost from the rise of high-throughput platforms, a trend that is reshaping the landscape of organ and tissue transplantation. High-throughput platforms, which enable the simultaneous analysis of multiple samples in a highly efficient and cost-effective manner, are revolutionizing the HLA typing process.

High-throughput platforms offer several advantages that are driving their increased adoption in the market. One of the most noteworthy benefits is the substantial increase in testing efficiency. These platforms can process a large number of samples in a single run, significantly reducing the time and resources required for HLA typing. This efficiency is a game-changer for clinical laboratories, allowing them to handle larger volumes of samples with greater speed and accuracy.

Moreover, the cost-effectiveness of high-throughput platforms is driving their popularity. By streamlining laboratory workflows and reducing the need for manual intervention, these platforms lower the overall cost per test. This cost-effectiveness benefits both healthcare providers and patients, making HLA typing more accessible and affordable. It is especially important in regions where healthcare resources are limited, and cost considerations play a critical role in patient care.

The rise of high-throughput platforms has also improved the accessibility of HLA typing services. Clinical laboratories that adopt these technologies can expand their testing capabilities, making HLA typing more widely available to patients in need of transplantation evaluations. This trend contributes to reducing waiting times and ensures that a larger number of individuals can receive timely compatibility assessments.

The efficiency of high-throughput platforms is not limited to HLA typing for organ and tissue transplantation; it also plays a crucial role in other applications, such as HLA typing for hematopoietic stem cell transplantation. As the demand for these procedures increases, the ability to process a greater number of samples simultaneously becomes vital..

*Increasing Use in Hematopoietic Stem Cell Transplantation*

The Global HLA Typing for Transplant Market is witnessing a significant boost in demand due to the increasing use of HLA typing in hematopoietic stem cell transplantation (HSCT). Hematopoietic stem cell transplantation, commonly used in the treatment of various hematological disorders, such as leukemia, lymphoma, and severe aplastic anemia, relies heavily on HLA compatibility between donors and recipients. This application of HLA typing is reshaping the landscape of the transplant market.

In HSCT, the goal is to replace the patient's damaged or malfunctioning bone marrow with healthy stem cells from a compatible donor. HLA compatibility plays a pivotal role in the success of this procedure. The HLA markers on the donor's stem cells must closely match those of the recipient to minimize the risk of graft-versus-host disease (GVHD) and graft failure. The more precise and accurate the HLA typing, the higher the chances of a successful transplant.

As the prevalence of hematological disorders continues to rise, there is a growing demand for HSCT procedures, driving the need for comprehensive HLA typing services. This trend not only emphasizes the importance of HLA compatibility but also stimulates innovation in HLA typing technologies. Laboratories and healthcare providers are increasingly adopting advanced techniques, such as Next-Generation Sequencing (NGS), to achieve more accurate HLA typing, ensuring optimal donor-recipient matches.

The expansion of HLA typing into the realm of hematopoietic stem cell transplantation is having a profound impact on the market. It not only increases the overall volume of HLA typing tests but also diversifies the applications of HLA typing services, further driving market growth. The broader range of services provided by clinical laboratories and healthcare institutions is meeting the growing demand for compatibility assessments in the context of HSCT, ensuring that patients receive the most accurate and beneficial donor matches.

*Key Attributes:*

*Report Attribute* *Details*
No. of Pages 185
Forecast Period 2024 - 2029
Estimated Market Value (USD) in 2024 $1.02 Billion
Forecasted Market Value (USD) by 2029 $1.45 Billion
Compound Annual Growth Rate 6.0%
Regions Covered Global

*Competitive Landscape*

Company Profiles: Detailed analysis of the major companies present in the Global HLA Typing for Transplant Market.

· Thermo Fisher Scientific, Inc.
· Illumina, Inc.
· Qiagen N.V.
· Bio-Rad Laboratories, Inc.
· F. Hoffmann-La Roche Ltd
· Immucor, Inc.
· Caredx. Inc.
· Luminex Corporation (Diasorin)
· Tbg Diagnostics Limited

*Report Scope:*

*HLA Typing for Transplant Market, By Product & Service:*

· Reagents & Consumables
· Instruments
· Software & Services

*HLA Typing for Transplant Market, By Technology:*

· Molecular Assay Technologies
· Non-molecular Assay Technologies

*HLA Typing for Transplant Market, By Application:*

· Diagnostic Applications
· Antibody Screening
· Chimerism Monitoring
· Research Applications
· Others

*HLA Typing for Transplant Market, By Transplant Type:*

· Solid Organ Transplant
· Soft Tissue Transplant

*HLA Typing for Transplant Market, By Region:*

· North America
· United States
· Canada
· Mexico
· Europe
· France
· United Kingdom
· Italy
· Germany
· Spain
· Asia-Pacific
· China
· India
· Japan
· Australia
· South Korea
· South America
· Brazil
· Argentina
· Colombia
· Middle East & Africa
· South Africa
· Saudi Arabia
· UAE

For more information about this report visit https://www.researchandmarkets.com/r/4h5ouy

*About ResearchAndMarkets.com*
ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.

*Attachment*

· Global HLA Typing for Transplant Market

CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood,Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./ CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900